31st Jan 2023 11:47
Uniphar PLC - Dublin-based healthcare business focusing on pharmaceutical and medical technology manufacturers - Says gross profit and earnings before interest, tax, depreciation and amortisation are expected to be in line with expectations, adding that its normalised free cashflow conversion has topped medium-term guidance. Achieves a 5% increase in organic gross profit for 2022, driven by "organic growth across each division and an outperformance in Supply Chain & Retail," Uniphar explains. In 2021 gross profit was EUR274.5 million. Read More
